Remove Chronic Condition Remove IT Remove Patient-Centered Remove Utilities
article thumbnail

Drs. Ansari and Davidoff on innovation and health care access

Permanente Medicine

To address the growing demand for health care services combined with workforce shortages, utilizing health care innovations that improve patient health and restore the joy in medicine for physicians and clinicians is more essential than ever. Connecting patients with needed care quickly creates a win-win for patients and care teams.

article thumbnail

RCT of Palliative Care for Heart Failure and Lung Disease: David Bekelman and Lyndsay DeGroot

GeriPal

He also found gaps, including very few studies of patients with lung disease, and little impact of trials on quality of life. Summary Transcript Summary In a JAMA 2020 systematic review of palliative care for non-cancer serious illness, Kieran Quinn found many positives, as we discussed on our podcast and in our editorial. Is it you Lyndsay?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

How State and Local Agencies on Aging Help Older Adults: Susan DeMarois, Greg Olsen, and Lindsey Yourman

GeriPal

Summary Transcript Summary You may have heard of Area Agencies on Aging, but do you really know what they do or how they do it? What about State Departments of Aging or state master plans for aging? Do you know how these agencies fit in with programs like Meals-on-Wheels or other nutritional support programs? Susan: It is my anthem.

article thumbnail

Guiding an Improved Dementia Experience (GUIDE) Model: A Podcast with Malaz Boustani and Diane Ty

GeriPal

Don’t get me wrong, the evidence points to cost savings, but as Chris Callahan and Kathleen Unroe pointed out in a JAGS editorial in 2020 “in comprehensive dementia care models, savings may accrue to Medicare, but the expenses accrue to a fluid and unstable network of local service providers, patients, and their families.” Malaz: I love it.

article thumbnail

Drug Pricing Reform Gathers Steam (Part 1): White House Drug Pricing Plan Offers Laundry List of Existing Democrat Priorities

FDA Law Blog

Medicare negotiation authority; encourage biosimilars and generic drug utilization). Controlling Medicare Part D Patient Out-of-Pocket Costs and Total Drug Costs. The Plan supports legislative action to control total drug costs and patient out-of-pocket (“OOP”) costs for Medicare Part D beneficiaries. Last Thursday, the U.S.